Personalis Inc [PSNL] stock prices are up 6.16% to $1.55 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The PSNL shares have gain 24.00% over the last week, with a monthly amount glided 10.71%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 28, February 2024, Personalis Reports Fourth Quarter and Full Year 2023 Financial Results. In a post published today on Yahoo Finance, Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today reported financial results for the fourth quarter and full year ended December 31, 2023, and provided recent business highlights.
From an analyst’s perspective:
Personalis Inc [NASDAQ: PSNL] stock has seen the most recent analyst activity on February 06, 2023, when Needham upgraded its rating to a Buy but kept the price target unchanged to $8 for it. Previously, Needham upgraded its rating to Buy on February 06, 2023. On January 07, 2022, upgrade upgraded it’s rating to Buy and revised its price target to $23 on the stock. Morgan Stanley downgraded its rating to a Equal-Weight. Needham downgraded its rating to a Hold. In a note dated September 20, 2021, Needham reiterated an Buy rating on this stock and revised its target price from $33 to $28.
The stock price of Personalis Inc [PSNL] has been fluctuating between $0.89 and $3.27 over the past year. Currently, Wall Street analysts expect the stock to reach $13 within the next 12 months. Personalis Inc [NASDAQ: PSNL] shares were valued at $1.55 at the most recent close of the market. An investor can expect a potential return of 738.71% based on the average PSNL price forecast.
Analyzing the PSNL fundamentals
The Personalis Inc [NASDAQ:PSNL] reported sales of 70.53M for trailing twelve months, representing a surge of 22.81%. Gross Profit Margin for this corporation currently stands at 0.22% with Operating Profit Margin at -1.62%, Pretax Profit Margin comes in at -1.6%, and Net Profit Margin reading is -1.6%. To continue investigating profitability, this company’s Return on Assets is posted at -0.5, Equity is -0.61 and Total Capital is -0.59. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.23.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.3633 points at the first support level, and at 1.1767 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.6833, and for the 2nd resistance point, it is at 1.8167.
Personalis Inc [PSNL] reported earnings per share of -$0.54 for its fiscal quarter that ended on 12/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.5/share, meaning a difference of -$0.04 and a surprise factor of -8.00%. By comparison, the stated earnings for the previous quarter ended on 9/29/2023 were -$0.6 per share as compared to estimates of -$0.53 per share, a difference of -$0.07 representing a surprise of -13.20%.
Ratios To Look Out For
It’s worth pointing out that Personalis Inc [NASDAQ:PSNL]’s Current Ratio is 4.47. Also, the Quick Ratio is 4.31, while the Cash Ratio stands at 2.22. Considering the valuation of this stock, the price to sales ratio is 1.08, the price to book ratio is 0.50.
Transactions by insiders
Recent insider trading involved Tachibana Aaron, CFO AND COO, that happened on Jan 29 when 716.0 shares were sold. CHIEF MEDICAL OFFICER AND EVP, Chen Richard completed a deal on Jan 29 to sell 526.0 shares. Meanwhile, CFO and COO Tachibana Aaron sold 6747.0 shares on Dec 15.
